Stock Events

Stock Events

Sonnet Biotherapeutics (SONN) Q4 2024 Earnings

17DecConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-6.12

-4.06

-1.99

0.07

Details

Expected EPS

-5.52

Actual EPS

-3.83

Surprise EPS

1.69

Surprise Percent

+30.62%

Description

Sonnet Biotherapeutics (SONN) has reported earnings of -3.83 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.